Tissue-type but not urokinase-type plasminogen activator is released after treatment of cultured normal human keratinocytes with autoantibodies to bullous pemphigoid antigen BP180

被引：0
|
作者：
Schmidt, E
Reimer, S
Marinkovich, MP
Bröcker, EB
Zillikens, D
机构：
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2000年 / 115卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：534 / 534
页数：1
相关论文
共 50 条
  • [1] Elevated expression and release of tissue-type, but not urokinase-type, plasminogen activator after binding of autoantibodies to bullous pemphigoid antigen 180 in cultured human keratinocytes
    Schmidt, E
    Wehr, B
    Tabengwa, EM
    Reimer, S
    Bröcker, EB
    Zillikens, D
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2004, 135 (03): : 497 - 504
  • [2] Differential effects of acute and chronic wound fluids on urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor, and tissue-type plasminogen activator in cultured human keratinocytes and fibroblasts
    Weckroth, M
    Vaheri, A
    Myöhänen, H
    Tukiainen, E
    Sirén, V
    WOUND REPAIR AND REGENERATION, 2001, 9 (04) : 314 - 322
  • [3] Localisation of bullous pemphigoid antigen 180 (BP180) in cultured human keratinocytes:: functionally relevant modification by calcium
    Schmidt, Enno
    Wehr, Barbara
    Wolf, Katharina
    Sitaru, Cassian
    Broecker, Eva B.
    Zillikens, Detlef
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2006, 298 (06) : 283 - 290
  • [4] Localisation of bullous pemphigoid antigen 180 (BP180) in cultured human keratinocytes: functionally relevant modification by calcium
    Enno Schmidt
    Barbara Wehr
    Katharina Wolf
    Cassian Sitaru
    Eva -B. Bröcker
    Detlef Zillikens
    Archives of Dermatological Research, 2006, 298 : 283 - 290
  • [5] Inhibition of urokinase-type and tissue-type plasminogen activator - Mediated plasminogen activation by doxycycline
    Hanemaaijer, R
    Visser, H
    vandenHoogen, CM
    Sorsa, T
    vanHinsbergh, VWM
    FIBRINOLYSIS, 1996, 10 : 109 - 111
  • [6] Plasma tissue-type plasminogen activator increases fibrinolytic activity of exogenous urokinase-type plasminogen activator
    Shenkman, Boris
    Livnat, Tami
    Budnik, Ivan
    Tamarin, Ilia
    Einav, Yulia
    Martinowitz, Uriel
    BLOOD COAGULATION & FIBRINOLYSIS, 2012, 23 (08) : 729 - 733
  • [7] Elevations of tissue-type plasminogen activator and differential expression of urokinase-type plasminogen activator in diseased aorta
    Shireman, PK
    McCarthy, WJ
    Pearce, WH
    Shively, VP
    Cipollone, M
    Kwaan, HC
    JOURNAL OF VASCULAR SURGERY, 1997, 25 (01) : 157 - 164
  • [8] Domain-domain interactions in hybrids of tissue-type plasminogen activator and urokinase-type plasminogen activator
    Bakker, AHF
    Nieuwenbroek, NME
    Verheijen, JH
    PROTEIN ENGINEERING, 1995, 8 (12): : 1295 - 1302
  • [9] Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator
    Bugge, TH
    Flick, MJ
    Danton, MJS
    Daugherty, CC
    Romer, J
    Dano, K
    Carmeliet, P
    Collen, D
    Degen, JL
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (12) : 5899 - 5904
  • [10] UROKINASE-TYPE AND TISSUE-TYPE PLASMINOGEN ACTIVATORS IN KERATINOCYTES DURING WOUND REEPITHELIALIZATION INVIVO
    GRONDAHLHANSEN, J
    LUND, LR
    RALFKIAER, E
    OTTEVANGER, V
    DANO, K
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1988, 90 (06) : 790 - 795
12345